La Renon

La Renon

Private
Ahmedabad, GujaratHealthcare & Life Scienceshttps://www.larenon.com

Last Round

Secondary

Dec 8, 2025

Est. Valuation

$1.26B

Total Funding Raised

$105.3M

Momentum Score

25 /100

Company Overview

La Renon is a healthcare company focused on treating chronic illnesses and diseases across various segments, including nephrology, neurology, critical care, gynecology, orthopedics, gastroenterology, urology, respiratory, and cardio-metabolic conditions, empowering healthcare professionals to enhance patient care and quality of life.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Pharma Supply Chain

Business Model

B2B2C

Customer Profile

Hardware Sales, Government Contracts

AI Layer

Non-AI

Keywords

branded genericspharmaceutical formulationsnephrologychronic disease managementkidney diseasecentral nervous systemCNS disordersactive pharmaceutical ingredientsAPIspecialty pharmapharmaceutical companypharmaceutical manufacturingcritical caregastroenterologyurologycardio-metabolic

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

La Renon Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

La Renon Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
SecondaryDec 8, 2025
Private EquityFeb 4, 2025
Private EquityApr 16, 2024
VC RoundJan 11, 2021
Series AJun 12, 2015

Key People

Founding team and executive leadership

Pankaj Singh

Chairman CEO

Executive Team

La Renon Investors

Notable investors and investment history

InvestorRounds
ChrysCapitalPrivate Equity
A91 PartnersVC Round
White Oak Capital ManagementSecondary
CreadorSecondary
Avendus Future Leaders FundPrivate Equity
Sequoia CapitalSeries A
Siguler GuffSecondary

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 1, 2025

    Ranked among the top 50 pharmaceutical companies in India.

  • Sep 13, 2025

    Investing in an oral solid dosage plant in Rajasthan to expand capacity.

La Renon Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

La Renon Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about La Renon's valuation, stock price, and market status.

Firmographic Details

HeadquartersAhmedabad, Gujarat
Employee Range1,163
Year Founded2007
Last FundingDec 8, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.